baber/WOPTO huggingface dataset:
Patent EP-3482191-A2 (EP)
Title: Étalonnage de lecteur de plaque, fonctionnement sécurisé et plaque de détachement perfectionnée
Inventor: MARKOVSKY ROBERT J
IPC: G01J1/02
Filed: 2017-04-28
Abstract: L'invention concerne des procédés, des opérations et des systèmes de lecteur et plaque pour l'imagerie/le comptage du développement biologique sur des plaques. Un mode de réalisation consiste à étalonner un lecteur de plaque. L'étalonnage peut être déclenché par détection d'un événement de contrôle de qualité ou similaire. Le procédé d'étalonnage peut comprendre la réception d'un dispositif d'étalonnage bas et/ou élevé, le comptage d'objets sur le(s) dispositif(s) d'étalonnage et la comparaison d'objets sur le(s) dispositif(s) d'étalonnage à une limite prédéfinie. Le résultat est un lecteur de plaque amélioré permettant d'observer la croissance biologique, lorsqu'elle est présente, sur une plaque de croissance.
Patent EP-3544505-A2 (EP)
Inventor: PREUSSIGER MARION
IPC: A61B5/1455
Filed: 2017-11-27
Abstract: The invention relates to a method for therapy control based on transcutaneous real-time detection of the bilirubin content in the blood. In an illumination step, light is irradiated onto a section of vital tissue and at least one portion of the light exiting from this tissue section is detected, with recordings of intensity and wavelength being evaluated using an evaluation procedure, and, in this evaluation procedure, the concentration of bilirubin is determined using a system of equations defined with concentrations of Hb and skin tissue, those concentrations of Hb and skin tissue being determined from absorption values at the wavelengths of isosbestic points of haemoglobin. The therapy is controlled in accordance with the concentration of bilirubin determined in this manner.
Patent EP-3376228-A2 (EP)
Title: Verfahren zum nachweis biogener amin-botenstoffe
Inventor: NEUMEIER BEATRICE LILLI
IPC: G01N33/58
Filed: 2018-03-16
Abstract: Die vorliegende Erfindung betrifft ein Verfahren zum Nachweis eines biogenen Amin-Botenstoffs in einem  ex-vivo  Schnelltest, umfassend die Schritte 
(a) in Kontakt bringen einer anorganisch-organischen Hybridverbindung in Form von Nanopartikeln mit einem Partikeldurchmesser im Bereich von 1 bis 100 nm, bestehend aus einem anorganischen Metall-Kation, ausgewählt aus der Gruppe, bestehend aus Cu + , Cu 2+ , Ag + , Zn 2+ , Au +  und Au 3+ , und einem organischen Fluoreszenzfarbstoff-Anion, das mindestens eine CarboxylatGruppe enthält, mit dem biogenen Amin-Botenstoff in einer Suspension, wobei die anorganisch-organische Hybridverbindung eine molare Löslichkeit in Wasser von höchstens 10 -2  mol/l aufweist und wobei das organische Fluoreszenzfarbstoff-Anion aufgrund der höheren Affinität des biogenen Amin-Botenstoffs zu dem anorganischen Metall-Kation in einer Menge relativ zu der Menge des biogenen Amin-Botenstoffs freigesetzt wird; 
(b) photometrisches Bestimmen der Konzentration des freien organischen Fluoreszenzfarbstoff-Anions; und 
(c) Korrelieren der Konzentration des freien organischen Fluoreszenzfarbstoff-Anions mit der Konzentration des biogenen Amin-Botenstoffs.
Patent EP-3447597-A2 (EP)
Inventor: MATSUI HIDEYUKI
IPC: G05D1/02
Filed: 2018-06-29
Abstract: An autonomous driving device includes a first map including a first content and a second content associated with positions respectively, a second map including the first content associated with the position and in which the second content is not a recording target, and a control unit performing the autonomous driving. When the autonomous driving is performed using the first map, the control unit determines information necessary for the autonomous driving using a first method based on the first content and the second content. When the autonomous driving is performed using the second map, the control unit determines the information necessary for the autonomous driving using a method same as the first method based on the first content corresponding to a second position recorded in the second map and information indicating that the second content corresponding to the second position recorded in the second map is not present.
Patent EP-3450552-A2 (EP)
Inventor: DEKKER PETRUS JACOBUS THEODORUS
IPC: C12N15/59
Filed: 2013-05-03
Abstract: A variant polypeptide having chymosin activity, wherein the variant has an amino acid sequence which, when aligned with the chymosin comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid residue corresponding to any of amino acids 2, 22, 40, 48, 50, 51, 53, 61, 62, 76, 88, 98, 99, 109, 112, 117, 125, 126, 135, 144, 160, 161, 163, 187, 189, 194, 200, 201, 202, 203, 221, 223, 240, 242, 244, 254, 267, 271, 273, 278, 280, 284, 289, 292, 294 or 295 
said positions being defined with reference to SEQ ID NO: 2 and wherein the variant has one or more altered properties as compared with a reference polypeptide having chymosin activity. Such a variant polypeptide may be used in the preparation of a cheese.
Patent EP-3550551-A2 (EP)
Inventor: CHEN CHAOXI
IPC: G09G3/3208
Filed: 2018-12-27
Abstract: The present disclosure relates to a display panel (20), a photoelectric detection method (300, 400), a photoelectric detection device (500) and a computer readable storage medium. The display panel (20) includes a pixel array (1) including a plurality of subpixels (11), through holes (12) are arranged within gaps among the plurality of subpixels (11), and a photoelectric detection unit (2) including a photoelectric detection array (21) configured to detect incident light passing through the through holes (12). The photoelectric detection method (300, 400) includes determining (301, 401) a plurality of target subpixels from the plurality of subpixels (11); determining (302, 402) a time period when the plurality of target subpixels do not emit light; and during the time period, detecting (303, 403) incident light passing through the through holes (12) by the photoelectric detection array (21).
Patent EP-3599918-A2 (EP)
Title: Nursing garment
Inventor: HJORT AMELIE
IPC: A41D1/215
Filed: 2018-03-23
Abstract: In accordance with one or more embodiments herein, a garment suitable for nursing is provided. The garment comprises an outer layer and an inner layer extending below the outer layer. The inner layer comprises an inner layer front section and an inner layer back section that are attached to each other at least at the sides, and the outer layer comprises an outer layer front section and an outer layer back section that are attached to each other at least at the sides. The inner layer and the outer layer are attached to each other in at least one point above the lowermost edges of the sleeve openings of the inner layer, and the outer layer comprises a lower edge arranged below the lowermost edges of the sleeve openings of the inner layer, so that a breast can be accessed through one of the sleeve openings of the inner layer by lifting the lower edge of the outer layer. The garment facilitates breastfeeding, since an outer layer which is not attached to the inner layer at the sides is easy to lift in order to access a breast through one of the sleeve openings of the inner layer.
Patent EP-3634501-A2 (EP)
Inventor: BENI STEFANO
IPC: A61L2/26
Filed: 2018-06-04
Abstract: Sterilizing machine (10) for loose products (P), comprising a treatment chamber (11) provided with a loading zone (14) for the loose products (P) to be treated. The sterilizing machine (10) comprises, upstream of the treatment chamber (11), a container (20) for loading the loose products (P) provided with a loading side (24) and an unloading side (26) of the loose products (P), and with movement means (36, 38) of the loose products (P) from the loading side (24) to the unloading side (26). The container (20) is associable, on the unloading side (26), with means (44) for sending the loose products (P) unloaded from the container (20) toward the loading zone (14) of the treatment chamber (11).
Patent EP-3630116-A2 (EP)
Title: Inhibiteurs de la kinase atr à base de tétrahydropyrido[4,3-d]pyrimidine
Inventor: DI FRANCESCO MARIA EMILIA
IPC: A61K31/519
Filed: 2018-05-25
Abstract: La présente invention concerne des composés à base de tétrahydropyrido[4,3- d ]pyrimidine et des procédés qui peuvent être utiles en tant qu'inhibiteurs de la kinase ATR pour le traitement ou la prévention du cancer.
Patent EP-3694403-A2 (EP)
Title: Valve coaptation measurement devices
Inventor: HOGANSON DAVID
IPC: A61B5/0215
Filed: 2018-10-15
Abstract: Methods, systems, and coaptation measurement devices as described herein include an elongate sensor body at the end of a proximal connecting member, and a plurality of sensors in an array across a face of the sensor body, wherein each sensor of the plurality of sensors is configured to detect if a portion of a heart valve is in contact with the sensor.
Patent EP-3807584-A2 (EP)
Title: A modular grenade launcher assembly
Inventor: YOLLU FATIH
IPC: F41A35/06
Filed: 2018-12-25
Abstract: The invention relates to a modular grenade launcher assembly (A) which use of a 40x46 and 40x 51 mm ammunition grenade launcher and which can be used with a portable rifle butt or can be mounted under a rifle.
Patent EP-3591771-A2 (EP)
Inventor: HULSCHER MARK E
IPC: H01R43/20
Filed: 2019-05-13
Abstract: Apparatus and methods for inserting and retention testing an electrically conductive contact (4a, 4b) in an electrical connector (2). The method includes the following steps: manually partially inserting the contact into a hole (1) formed inside the electrical connector; inserting the contact further into the hole by pushing the contact along an axis using an insertion tip (41) that is aligned with the axis and that displaces in a first direction along the axis during inserting; and after inserting the contact further into the hole, testing retention of the contact inside the electrical connector by pushing the contact along the axis using a test probe (46) that is aligned with the axis and that displaces in a second direction opposite to the first direction during retention testing. The force exerted by the test probe on the contact is less than a specified contact retention force. The method further includes generating an alert signal if the test probe displaces along the axis in the second direction by more than a specified distance during retention testing.
Patent EP-3552571-A2 (EP)
Inventor: ZABAR YOEL
IPC: A61N5/067
Filed: 2015-05-18
Abstract: Systems for enabling delivery of very high peak power laser pulses through optical fibers for use in ablation procedures preferably in contact mode. Such lasers advantageously emit at 355nm wavelength. Other systems enable selective removal of undesired tissue within a blood vessel, while minimizing the risk of damaging the blood vessel itself, based on the use of the ablative properties of short laser pulses of 320 to 400nm laser wavelength, with selected parameters of the mechanical walls of the tubes constituting the catheter, of the laser fluence and of the force that is applied by the catheter on the tissues. Additionally, a novel method of calibrating such catheters is disclosed, which also enables real time monitoring of the ablation process. Additionally, novel methods of protecting the fibers exit facets are disclosed.
Patent EP-3626287-A2 (EP)
Inventor: CABIRI OZ
IPC: A61M5/315
Filed: 2016-09-22
Abstract: A method and system are disclosed for driving a plunger in a drug reservoir. In some embodiments, a variable friction element interconnects between a pushing shaft and a wall of the reservoir. For example, rotation of a driving element in a first direction relative to the pushing shaft may advance the pushing shaft in the reservoir. The friction element may have increased friction resistance to rotation of the pushing shaft in the first direction in comparison to frictional resistance to advancing the pushing shaft. For example, the increased friction may result from wedging a radial element between the pushing shaft and the wall of the reservoir.
Patent EP-3888174-A2 (EP)
Title: Wässriger elektrolyt, redox-flow-batterie und deren verwendung
Inventor: SCHUBERT ULRICH SIGMAR
IPC: H01M8/18
Filed: 2019-11-27
Abstract: Beschrieben wird eine wässrige Elektrolytlösung mit einer Temperatur von mindestens 30°C enthaltend eine Verbindung mit mindestens einem redoxaktiven Rest der Formel (I) (X-C 5 H 4 ) Fe (Y-C 5 H 3 -Z) (I), worin X ein Rest der Formel -(C n H 2 n)-FG oder der Formel -(C n H 2 n)-Sp-(C n H 2n )-FG oder der Formel -(C n H 2 n)-Brgp- ist, Y Wasserstoff oder einen Rest der Formel -(C n H 2 n)-FG oder der Formel -(C n H 2 n)-Sp-(C n H 2 n)-FG bedeutet, Z Wasserstoff ist oder eine kovalente Bindung bedeutet, welche den Rest der Formel (I) mit dem restlichen Molekül verbindet, FG eine funktionelle Gruppe ausgewählt aus -OH, -NO 3 , -NO 2 , - CN, -OR 1 , -(O-CH 2 -CH 2 ) o -OR 2 , -(O-CH 2 -CH 2 ) o  -NR 3 R 4 R 5 
 +  (An m- ) 1/m , -COR 2 , -COO" (Kat m+ ) 1/m , - COOR 2 , -SO 3 - (Kat m+ ) 1/m , -SO 3 R 2 , -S0 4 
 -  (Kat m+ ) 1/m , -SO 4 R 2 , -PO 4 
 2-  (Kat m+ ) 2/ m > -PO 4 (R 2 ) 2 , -PO 3 
 2-  (Kat m+ ) 2/m , -PO 3 (R 2 )2, -NR 3 R 4 R 5 + (An m- ) 1/m , -N + R 3 R 4 -C t H 2t -S0 3 - oder — NR 2 -SO 2 -R 3  ist, Brgp eine zweibind ige Brückengruppe ist, welche den Rest der Formel (I) mit dem restlichen Molekül verbindet, Sp -O-, -S-, -SO- oder -S0 2 - ist, R 1  C 1 -C 4  Alkyl ist, R 2  Wasserstoff oder C 1 -C 4  Alkyl ist, R 3 , R 4  und R 5  unabhängig voneinander Wasserstoff oder Alkyl bedeuten, Kat ein m-wertiges Kation ist, An ein m-wertiges Anion ist, m eine ganze Zahl zwischen 1 und 4 bedeutet, n eine ganze Zahl zwischen 2 und 4 darstellt, t eine ganze Zahl zwischen 2 und 5 ist, und o eine ganze Zahl von 1 bis 50, vorzugsweise von 3 bis 20, ist. Der Elektrolyt lässt sich in Redox-Flow-Batterien einsetzen und zeichnet sich durch eine hohe Stabilität der redoxaktiven Verbindungen bei erhöhten Temperaturen aus.
Patent EP-3898055-A2 (EP)
Inventor: UECKER JAMES
IPC: B23K9/173
Filed: 2019-12-19
Abstract: An example contact tip for a welding torch includes: a first body section having a first diameter and exterior threads, the first body section having channels extending longitudinally along an exterior surface of the first body section to permit gas flow from a first end of the contact tip to a second end of the contact tip through the channels; a first bore portion having a first inner diameter; and a second bore portion having a second inner diameter configured to contact an electrode wire traveling through the second bore portion, the first inner diameter being larger than the second inner diameter.
Patent EP-3847078-A2 (EP)
Inventor: SAUVAGEAU YVES
IPC: B62D55/00
Filed: 2019-09-06
Abstract: A track system for use with a vehicle includes an attachment assembly connectable to the chassis of the vehicle having a first pivot extending vertically and defining a yaw pivot axis of the track system, and a second pivot extending laterally and defining a pitch pivot axis of the track system. A frame assembly is disposed laterally outwardly from the attachment assembly and connected thereto. The frame assembly includes at least one wheel-bearing frame member. The track system further includes at least one actuator connected between the attachment assembly and the frame assembly for pivoting the frame assembly about the yaw pivot axis, a leading idler wheel assembly at least indirectly connected to the at least one wheel-bearing frame member, a trailing idler wheel assembly at least indirectly connected to the at least one wheel-bearing frame member, at least one support wheel assembly, and an endless track.
Patent EP-3870379-A2 (EP)
Inventor: CETIN HAYDAR
IPC: B22C3/00
Filed: 2019-10-07
Abstract: La présente invention concerne un revêtement qui est particulièrement approprié pour être appliqué sur des moules et/ou des noyaux en sable utilisés pour des procédés de coulage de fer et d'acier, et un procédé de production de ce revêtement. Le revêtement comprend au moins un liquide porteur; au moins un matériau réfractaire sous la forme d'une poudre; au moins un agent rhéologique; et au moins un agent de suspension. Le procédé de production comprend les étapes consistant à : placer au moins un liquide porteur et au moins un agent rhéologique dans un mélangeur; faire fonctionner le mélangeur à une vitesse élevée pour permettre la dispersion homogène de l'agent rhéologique dans le mélangeur; et ajouter au moins un matériau réfractaire sous la forme d'une poudre au mélangeur.
Patent EP-3991212-A2 (EP)
Inventor: KRYLIOUK OLGA
IPC: H01L33/00
Filed: 2020-06-22
Abstract: The present disclosure relates to a method for manufacturing an optoelectronic device (70) comprising forming, by metal-organic chemical vapor deposition, MOCVD, wire-shaped, conical, or frustoconical semiconductor elements (34) made of a III-V compound, doped or undoped, each semiconductor element extending along an axis (C) and comprising a top (35), and forming by remote plasma chemical vapor deposition, RPCVD, or by molecular-beam epitaxy, MBE, or by hydride vapor phase epitaxy, HVPE, for each semiconductor element, an active area (44) only on said top comprising at least a first semiconductor layer made of the III-V compound and a second semiconductor layer made of the III-V compound and an additional group-III element.
Patent EP-3930635-A2 (EP)
Inventor: CHAROENSUK WARAKORN
IPC: A61F2/68
Filed: 2020-02-25
Abstract: The present invention relates to a device for grasping an object, the device comprises an actuator providing a primary force; a proximal element proximal to the actuator; and a tip element distal to the actuator, wherein the actuator provides a primary force on the proximal and tip elements; the proximal and tip elements are coupled by a pivot point connected by a cable to the actuator, and an elastic mechanism acts on the cable to provide a secondary force which displaces the proximal and tip elements towards the object. The present invention also relates to a method of of controlling a device for grasping an object and myoelectric prosthetic hand.
Patent EP-4070096-A2 (EP)
Inventor: KELM JENS MICHAEL
IPC: A61L2/00
Filed: 2020-12-03
Abstract: The present invention relates to methods, and devices to analyze the phenotype and/or genotype of cells obtained from tissue samples. In particular, the present invention relates to the analysis of the response of the cells as obtained to the exposure of a drug compound or combinations thereof. The methods of the present invention offer the particular advantage of being time-effective, and suitable for automatization.
Patent EP-4054670-A2 (EP)
Title: Medical fluid delivery system including analytics for managing patient engagement and treatment compliance
Inventor: GARCIA CHRISTY ELIZABETH
IPC: G16H20/10
Filed: 2020-11-05
Abstract: A medical fluid delivery system including analytics for managing patient engagement and treatment compliance is disclosed. In an example, an interface device receives treatment data from a dialysis machine for a patient undergoing dialysis. An analytics processor determines dialysis treatment parameter values by comparing the treatment data to a record of a prescribed therapy or program. The dialysis treatment parameter values may include a lost treatment time parameter value, a lost dwell time parameter value, and/or a completed treatment days parameter value. The analytics processor causes the dialysis treatment parameter values to be displayed within a user interface on a clinician device. The dialysis treatment parameter values provide an indication as to how well the patient is complying with the prescribed therapy or program, and may be used by a clinician to help a patient improve compliance if needed.
Patent EP-4058050-A2 (EP)
Inventor: KHALILI KAMEL
IPC: A61K38/46
Filed: 2020-11-11
Abstract: Provided herein are gene editing compositions and methods that effectively modulate and/or edit a JCV genome. The effective modulation and/or editing is, in an aspect, achieved by gene editing compositions targeting a NCCR region, an early coding gene, and/or a late coding gene.
Patent EP-3991598-A2 (EP)
Inventor: COOK ROBERT
IPC: A45D34/04
Filed: 2021-10-21
Abstract: A container comprising a container body is disclosed. The container is open at one end, to receive a liquid and defining a retaining volume to retain a liquid. A housing is secured to said container body, the housing retaining an applicator to deliver liquid to a surface. The housing is configured to control release of fluid from the container body. The container comprises two portions, releasably secured to each other and movable between a first position in which the two portions sealingly co-operate to define a volume to retain a liquid and a second position in which liquid can be added to the container body. The housing can include a dispensing mechanism secured to a container body, allowing a liquid to be dispensed.
Patent EP-4146096-A2 (EP)
Inventor: O'SHEA CONOR
IPC: A61B17/00
Filed: 2021-05-06
Abstract: A cutting assembly for a surgical instrument including an outer hub, an outer tube, a cutting implement, and a drive hub. A retention flange of the drive hub is arranged to retain the cutting shaft within the outer tube. The cutting assembly may include a seal, and the retention flange may contact the seal. An irrigation spacer may provide a stop of distal axial movement of the drive hub for permitting fluid to flow through irrigation passageways. The drive assembly may include an irrigation port and a suction port with a proximal end of the irrigation port may positioned axially distal to a proximal portion of the suction port. The irrigation port may be coupled to a handpiece, and the suction port may be coupled to a back cap. A handpiece may include a saddle region, recesses, and/or an apex region to facilitate ergonomic handling of the surgical instrument.
Patent EP-4172074-A2 (EP)
Inventor: FRISSENBICHLER WERNER JOSEF
IPC: B65G21/08
Filed: 2021-06-23
Abstract: Die vorliegende Erfindung betrifft ein Rollenshuttle und eine Hängerollenshuttle jeweils verfahrbar und ausgestattet mit einem einen Lastdorn (22) zum Transportieren mindestens einer zu lagernden Rolle. Bei dem Rollenshuttle ist der Lastdorn (22) an dem Laufschlitten (16) in einer zur Lagerebene eines Regalsystems im Wesentlichen parallelen Ebene schwenkbar befestigt. Das Hängerollenshuttle (42) ist entlang einer Laufschiene (40) verfahrbar. Die vorliegende Erfindung betrifft zudem ein Regalsystem und ein Hängeschienensystem inklusive Verteilstationen sowie ein Verfahren zum Betreiben des erfindungsgemäßen Regalsystems.
Patent EP-4136141-A2 (EP)
Inventor: GAGNER JENNIFER E
IPC: G03G9/087
Filed: 2021-04-16
Abstract: The present invention relates to a method and reagents for determining the presence of or the amount of an analyte in a sample.
Patent EP-4211857-A2 (EP)
Inventor: HUANG YI
IPC: H04L5/00
Filed: 2021-09-10
Abstract: Aspects described herein relate to providing demodulation reference signal (DMRS) transmissions for channel transmission repetitions. This can include defining DMRS patterns for channel transmission repetitions having a symbol length that is less than a threshold, dropping or deferring channel transmission repetitions that are mapped to a set of uplink symbols that are less than a threshold symbol length, and/or the like.
Patent EP-4271404-A2 (EP)
Title: Methods and compositions for modulating car-t activity
Inventor: SCHREPFER SONJA
IPC: A61K39/00
Filed: 2021-12-23
Abstract: Disclosed herein are engineered cells and/or hypoimmunogenic cells including engineered and/or hypoimmunogenic stem cells, engineered and/or hypoimmunogenic cells differentiated therefrom, engineered and/or hypoimmunogenic CAR-T cells (primary or differentiated from engineered and/or hypoimmunogenic stem cells) and related methods of their use and generation. Provided herein are engineered and/or hypoimmunogenic cells exhibiting reduced expression of MHC class I and/or MHC class II human leukocyte antigens and T-cell receptors. In some embodiments, such cells also exogenously express one or more tolerogenic factors such as CD47 and one or more chimeric antigen receptors (CAR)s.